0001209191-16-140980.txt : 20160912 0001209191-16-140980.hdr.sgml : 20160912 20160912180432 ACCESSION NUMBER: 0001209191-16-140980 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160909 FILED AS OF DATE: 20160912 DATE AS OF CHANGE: 20160912 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARATANA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001509190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383826477 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 CITY: LEAWOOD STATE: KS ZIP: 66211 BUSINESS PHONE: 913.353.1000 MAIL ADDRESS: STREET 1: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 CITY: LEAWOOD STATE: KS ZIP: 66211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TOOMAN CRAIG A CENTRAL INDEX KEY: 0001201050 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35952 FILM NUMBER: 161881698 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-09-09 0 0001509190 ARATANA THERAPEUTICS, INC. PETX 0001201050 TOOMAN CRAIG A C/O ARATANA THERAPEUTICS, INC. 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 0 1 0 0 CHIEF FINANCIAL OFFICER COMMON STOCK 2016-09-09 4 S 0 30000 9.2533 D 72424 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2016. This sale constitutes the final sale under such trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.095 to $9.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Craig A. Tooman 2016-09-12